THORP CLAY exercised options at PHASEBIO PHARMACEUTICALS INC
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 5/19/2023ACC: 0001169245-23-000032
Director10% Owner
Since Oct 2018
+7.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
7.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
11.4%
5/19/2023
32.94K→36.69K
Total
Net shares
+3.75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/19/2023 | M · Option Exercise | +3.75K | — | — | 11.4% | 32.94K | 36.69K |
| Total | +3.75K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
3.75K shares
Shares
+3.75K
Strike price
Held after
0.00
Exercisable
—
5/19/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.75K shares | 5/19/2023 | M · Option Exercise | +3.75K | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned3.55M
Total
3.55M indirect3.55M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.55M | Indirect |
| Total | 3.55M | 3.55M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported